{
  "docId": "019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "docSlug": "bb36c74f657a",
  "documentTitle": "Pulse Biosciences (PLSE)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-03 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 5,
  "pageCount": 13,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a screenshot of a technical presentation to undermine the company's technological claims.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-cb61f3b5c0ba/5",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Dr. Vivek Reddy, Pulse’s Own Hired Consultant, States There Isn’t An Advantage To Using Nano-second PFA Compared to Micro-Second PFA For Most Procedures",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8663-4ecb74cc7a71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.58,
        "x": 0.21,
        "y": 0.36
      },
      "kind": "image",
      "text": "Screenshot of Dr. Reddy's presentation slide detailing the Nanosecond PFA Catheter.",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2036bee5-f3b7-439d-8cc8-e7b195299977",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.85,
        "x": 0.08,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "PLSE’s catheter is far from being approved for commercial use. It lacks magnetic sensors and isn’t an over-the-wire system. The lack of magnetic sensors prevents it from using standard magnetic mapping. Instead, electrical impedance mapping was used, which positions the catheter inaccurately; ICE catheter and fluoro imaging had to be used to verify the catheter position.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10f3684a-4f83-4997-a257-780129cba1ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.85,
        "x": 0.08,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Dr. Vivek Reddy did a presentation at the 29th Annual International Atrial Fibrillation Symposium, showcasing his work on PLSE’s feasibility study. This was in February 2024. At the :21 time mark, Dr. Reddy discloses that he has an equity stake/stock options in PLSE, Kardium, and a slew of other MedTech companies in the PFA field.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dab6eeb-2471-4c5f-aa27-af579842f20e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.08,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "Because the Catheter 360 is not an Over-the-Wire system, its application is limited to a regional ablation according to Dr. Reddy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2a98c52-de07-4ba0-90b3-fabe1c79f75c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Ed: Just a quick question. If you can comment, since we have a lot of data with micro-second pulse field ablation, what are the theoretical benefits to nano-second? Is there less skeletal muscle stimulation or what’s the potential advantage? — Ed (Audience Member at AF Symposium 2024)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8663-50439aadef31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.08,
        "y": 0.14
      },
      "kind": "title",
      "text": "Dr. Vivek Reddy, Pulse’s Own Hired Consultant, States There Isn’t An Advantage To Using Nano-second PFA Compared to Micro-Second PFA For Most Procedures",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dac5dfd8-99ac-46a6-ab84-14510c3efe35",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 2,
      "beatId": "fcde8679-d26a-45e2-ad0b-301ddbdb4ca3",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The document presents contradictory information about Pulse Biosciences, such as its competitor Kardium's success and Dr. Vivek Reddy's statement about the advantage of nano-second PFA.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 2,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "1071288f-f643-4626-b233-d55a73d5a78a",
      "evidence": "The document presents a pattern of Pulse Biosciences' failure and weakness, including its history of failure and weak clinical results.",
      "position": 0,
      "objective": "To identify patterns in Pulse Biosciences' failure and weakness",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}